| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |